Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DaxibotulinumtoxinA for Platysma Bands
NCT06225492Phase 4Completed
- Sponsor
- Main Line Center for Laser Surgery
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in Platysmal Bands, sponsored by Main Line Center for Laser Surgery. Started Jan 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Platysmal Bands
Beyond the preview
Go deeper on NCT06225492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06225492.